Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Adenocarcinoma in ectopic prostatic tissue at dome of bladder: a case report of a patient with urothelial carcinoma of the bladder and adenocarcinoma of the prostate.

Gardner JM, Khurana H, Leach FS, Ayala AG, Zhai J, Ro JY.

Arch Pathol Lab Med. 2010 Sep;134(9):1271-5. doi: 10.1043/2009-0338-CR.1.

PMID:
20807045
2.

Mismatch repair expression in testicular cancer predicts recurrence and survival.

Velasco A, Corvalan A, Wistuba II, Riquelme E, Chuaqui R, Majerson A, Leach FS.

Int J Cancer. 2008 Apr 15;122(8):1774-7.

3.

CDC4 gene expression as potential biomarker for targeted therapy in prostate cancer.

Koh MS, Ittmann M, Kadmon D, Thompson TC, Leach FS.

Cancer Biol Ther. 2006 Jan;5(1):78-83. Epub 2006 Jan 31.

PMID:
16357515
4.

Tissue microarray analysis of hMSH2 expression predicts outcome in men with prostate cancer.

Prtilo A, Leach FS, Markwalder R, Kappeler A, Burkhard FC, Cecchini MG, Studer UE, Thalmann GN.

J Urol. 2005 Nov;174(5):1814-8; discussion 1818.

PMID:
16217293
5.

[Immunohistochemical and molecular analyis of mismatch repair genes in germ cell tumors].

Velasco Palma A, Riquelme Sánchez E, Schulze Maroto M, Villarroel del Pino L, Leach FS.

Actas Urol Esp. 2005 Feb;29(2):198-206. Spanish.

PMID:
15881919
6.

Prostate specific antigen as a clinical biomarker for prostate cancer: what's the take home message?

Leach FS, Koh MS, Chan YW, Bark S, Ray R, Morton RA, Remaley AT.

Cancer Biol Ther. 2005 Apr;4(4):371-5. Epub 2005 Apr 28.

PMID:
15846084
7.

Microsatellite instability and loss of heterozygosity have distinct prognostic value for testicular germ cell tumor recurrence.

Velasco A, Riquelme E, Schultz M, Wistuba II, Villarroel L, Koh MS, Leach FS.

Cancer Biol Ther. 2004 Nov;3(11):1152-8; discussion 1159-61. Epub 2004 Nov 9.

PMID:
15492498
8.

Mismatch repair gene expression and genetic instability in testicular germ cell tumor.

Velasco A, Riquelme E, Schultz M, Wistuba II, Villarroel L, Pizarro J, Berlin A, Ittmann M, Koh MS, Leach FS.

Cancer Biol Ther. 2004 Oct;3(10):977-82. Epub 2004 Oct 2.

PMID:
15467433
9.

Linking human genetics with molecular medicine: will hereditary renal cancer play a major role?

Leach FS.

Cancer Biol Ther. 2004 May;3(5):441-6. Epub 2004 May 18. Review.

PMID:
15004532
10.

Decreased expression of bone morphogenetic protein (BMP) receptor type II correlates with insensitivity to BMP-6 in human renal cell carcinoma cells.

Kim IY, Lee DH, Lee DK, Kim BC, Kim HT, Leach FS, Linehan WM, Morton RA, Kim SJ.

Clin Cancer Res. 2003 Dec 1;9(16 Pt 1):6046-51.

11.

Detection of mismatch repair gene expression in urologic malignancies.

Leach FS.

Methods Mol Biol. 2003;222:491-9. No abstract available.

PMID:
12710707
12.

Mismatch repair gene mutations in renal cell carcinoma.

Leach FS, Koh M, Sharma K, McWilliams G, Talifero-Smith L, Codd A, Olea R, Elbahloul O.

Cancer Biol Ther. 2002 Sep-Oct;1(5):530-6.

PMID:
12496483
13.

Clinicopathologic implications of hMSH2 gene expression and microsatellite instability in prostate cancer.

Velasco A, Albert PS, Rosenberg H, Martinez C, Leach FS.

Cancer Biol Ther. 2002 Jul-Aug;1(4):362-7.

PMID:
12432247
14.

Microsatellite instability and prostate cancer: clinical and pathological implications.

Leach FS.

Curr Opin Urol. 2002 Sep;12(5):407-11. Review.

PMID:
12172428
15.

Differential expression of the mismatch repair gene hMSH2 in malignant prostate tissue is associated with cancer recurrence.

Velasco A, Hewitt SM, Albert PS, Hossein M, Rosenberg H, Martinez C, Sagalowsky AI, McConnell JD, Marston W, Leach FS.

Cancer. 2002 Feb 1;94(3):690-9. Erratum in: Cancer 2002 May 15;94(10):2800.

16.

The mismatch repair gene hMSH2 is mutated in the prostate cancer cell line LNCaP.

Leach FS, Velasco A, Hsieh JT, Sagalowsky AI, McConnell JD.

J Urol. 2000 Nov;164(5):1830-3.

PMID:
11025778
17.

Expression of the human mismatch repair gene hMSH2: a potential marker for urothelial malignancy.

Leach FS, Hsieh JT, Molberg K, Saboorian MH, McConnell JD, Sagalowsky AI.

Cancer. 2000 May 15;88(10):2333-41.

PMID:
10820356
18.

Laparoscopic creation of a catheterizable cutaneous ureterovesicostomy.

Strand WR, McDougall EM, Leach FS, Allen TD, Pearle MS.

Urology. 1997 Feb;49(2):272-5.

PMID:
9037296
19.

Evaluation of the FHIT gene in colorectal cancers.

Thiagalingam S, Lisitsyn NA, Hamaguchi M, Wigler MH, Willson JK, Markowitz SD, Leach FS, Kinzler KW, Vogelstein B.

Cancer Res. 1996 Jul 1;56(13):2936-9.

20.

Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers.

Thiagalingam S, Lengauer C, Leach FS, Schutte M, Hahn SA, Overhauser J, Willson JK, Markowitz S, Hamilton SR, Kern SE, Kinzler KW, Vogelstein B.

Nat Genet. 1996 Jul;13(3):343-6.

PMID:
8673134
21.

Expression of the human mismatch repair gene hMSH2 in normal and neoplastic tissues.

Leach FS, Polyak K, Burrell M, Johnson KA, Hill D, Dunlop MG, Wyllie AH, Peltomaki P, de la Chapelle A, Hamilton SR, Kinzler KW, Vogelstein B.

Cancer Res. 1996 Jan 15;56(2):235-40.

22.

Mutations in DNA mismatch repair genes are not responsible for microsatellite instability in most sporadic endometrial carcinomas.

Katabuchi H, van Rees B, Lambers AR, Ronnett BM, Blazes MS, Leach FS, Cho KR, Hedrick L.

Cancer Res. 1995 Dec 1;55(23):5556-60.

23.

Monoallelic mutation analysis (MAMA) for identifying germline mutations.

Papadopoulos N, Leach FS, Kinzler KW, Vogelstein B.

Nat Genet. 1995 Sep;11(1):99-102.

PMID:
7550326
24.

Three dinucleotide repeat polymorphisms proximal to the D2S123 locus.

Leach FS, Nicolaides NC, Sistonen P, Yu JW, Kao FT, de la Chapelle A, Kinzler KW, Vogelstein B.

Hum Mol Genet. 1994 Nov;3(11):2082. No abstract available.

PMID:
7874140
25.

Mismatch repair genes on chromosomes 2p and 3p account for a major share of hereditary nonpolyposis colorectal cancer families evaluable by linkage.

Nyström-Lahti M, Parsons R, Sistonen P, Pylkkänen L, Aaltonen LA, Leach FS, Hamilton SR, Watson P, Bronson E, Fusaro R, et al.

Am J Hum Genet. 1994 Oct;55(4):659-65.

26.

Detection of genetic loss in tumors by representational difference analysis.

Lisitsyn NA, Leach FS, Vogelstein B, Wigler MH.

Cold Spring Harb Symp Quant Biol. 1994;59:585-7. No abstract available.

PMID:
7587116
27.

Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer.

Leach FS, Nicolaides NC, Papadopoulos N, Liu B, Jen J, Parsons R, Peltomäki P, Sistonen P, Aaltonen LA, Nyström-Lahti M, et al.

Cell. 1993 Dec 17;75(6):1215-25.

PMID:
8261515
28.

p53 Mutation and MDM2 amplification in human soft tissue sarcomas.

Leach FS, Tokino T, Meltzer P, Burrell M, Oliner JD, Smith S, Hill DE, Sidransky D, Kinzler KW, Vogelstein B.

Cancer Res. 1993 May 15;53(10 Suppl):2231-4.

29.

Clues to the pathogenesis of familial colorectal cancer.

Aaltonen LA, Peltomäki P, Leach FS, Sistonen P, Pylkkänen L, Mecklin JP, Järvinen H, Powell SM, Jen J, Hamilton SR, et al.

Science. 1993 May 7;260(5109):812-6.

PMID:
8484121
30.

Genetic mapping of a locus predisposing to human colorectal cancer.

Peltomäki P, Aaltonen LA, Sistonen P, Pylkkänen L, Mecklin JP, Järvinen H, Green JS, Jass JR, Weber JL, Leach FS, et al.

Science. 1993 May 7;260(5109):810-2.

PMID:
8484120
31.

Amplification of cyclin genes in colorectal carcinomas.

Leach FS, Elledge SJ, Sherr CJ, Willson JK, Markowitz S, Kinzler KW, Vogelstein B.

Cancer Res. 1993 May 1;53(9):1986-9.

33.

Supplemental Content

Loading ...
Support Center